UY32142A - Preparación de una quinoliniloxidifenilciclopropanodicarboxamida - Google Patents
Preparación de una quinoliniloxidifenilciclopropanodicarboxamidaInfo
- Publication number
- UY32142A UY32142A UY0001032142A UY32142A UY32142A UY 32142 A UY32142 A UY 32142A UY 0001032142 A UY0001032142 A UY 0001032142A UY 32142 A UY32142 A UY 32142A UY 32142 A UY32142 A UY 32142A
- Authority
- UY
- Uruguay
- Prior art keywords
- preparation
- quinoliniloxidifenilciclopropanodicarboxamida
- compound
- relates
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
- Indole Compounds (AREA)
Abstract
La presente invención se refiere a un procedimiento para preparar un compuesto de la fórmula III siguiente: en el que R1-R4 son como se define en la presente memoria. La presente invención también se refiere a la preparación de compuestos intermedios usados para preparar el compuesto de fórmula III:
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10045208P | 2008-09-26 | 2008-09-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY32142A true UY32142A (es) | 2010-05-31 |
Family
ID=42058136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001032142A UY32142A (es) | 2008-09-26 | 2009-09-24 | Preparación de una quinoliniloxidifenilciclopropanodicarboxamida |
Country Status (8)
Country | Link |
---|---|
US (1) | US8314232B2 (es) |
EP (1) | EP2339918A4 (es) |
JP (1) | JP5587324B2 (es) |
CN (1) | CN102227164A (es) |
AR (1) | AR075084A1 (es) |
TW (1) | TW201035017A (es) |
UY (1) | UY32142A (es) |
WO (1) | WO2010036831A1 (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2011119478A (ru) | 2008-10-14 | 2012-11-27 | Нин Си | Соединения и способы применения |
TWI447108B (zh) | 2009-01-16 | 2014-08-01 | Exelixis Inc | N-(4-{〔6,7雙(甲氧基)喹啉-4-基〕氧基}苯基)-n’-(4-氟苯基)環丙烷-1,1-二甲醯胺之蘋果酸鹽及其結晶型 |
AU2010229147B2 (en) | 2009-03-21 | 2012-07-05 | Sunshine Lake Pharma Co., Ltd. | Amino ester derivatives, salts thereof and methods of use |
UA108618C2 (uk) | 2009-08-07 | 2015-05-25 | Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку | |
AU2011245248B2 (en) * | 2010-04-29 | 2016-01-07 | Deciphera Pharmaceuticals, Llc | Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activites |
CN103221035A (zh) | 2010-07-16 | 2013-07-24 | 埃克塞里艾克西斯公司 | C-met调节剂药物组合物 |
EP2621481B2 (en) | 2010-09-27 | 2022-10-19 | Exelixis, Inc. | Dual inhibitors of met and vegf for the treatment of castration-resistant prostate cancer and osteoblastic bone metastases |
KR20190049907A (ko) | 2011-02-10 | 2019-05-09 | 엑셀리시스, 인코포레이티드 | 퀴놀린 화합물들의 제조 방법들 및 상기 화합물들을 함유하는 약학 조성물들 |
US20120252840A1 (en) | 2011-04-04 | 2012-10-04 | Exelixis, Inc. | Method of Treating Cancer |
EA029506B1 (ru) | 2011-05-02 | 2018-04-30 | Экселиксис, Инк. | Способ лечения рака и раковой боли в костях |
EA201490676A1 (ru) | 2011-09-22 | 2015-02-27 | Экселиксис, Инк. | Способ лечения остеопороза |
TWI619694B (zh) * | 2011-10-20 | 2018-04-01 | 艾克塞里克斯公司 | 用於製備喹啉衍生物之方法 |
EP2844254A1 (en) | 2012-05-02 | 2015-03-11 | Exelixis, Inc. | A dual met - vegf modulator for treating osteolytic bone metastases |
CN103664776B (zh) * | 2012-09-26 | 2016-05-04 | 正大天晴药业集团股份有限公司 | 一种酪氨酸激酶抑制剂及其中间体的制备方法 |
CN102977014B (zh) * | 2012-11-05 | 2015-01-07 | 沈阳药科大学 | 新的喹啉类化合物及其用途 |
CN102964308B (zh) * | 2012-11-30 | 2015-03-18 | 中国药科大学 | 新型嘧啶类化合物、其制备方法、包含此类化合物的药物组合物及其用途 |
CN103044263A (zh) * | 2013-01-14 | 2013-04-17 | 中国药科大学 | 一种治疗囊性纤维化药物的中间体的制备方法 |
CN103965104B (zh) * | 2013-01-29 | 2017-09-29 | 正大天晴药业集团股份有限公司 | 一种酪氨酸激酶抑制剂及其中间体的制备方法 |
CN105121412B (zh) | 2013-03-15 | 2019-07-12 | 埃克塞里艾克西斯公司 | N-(4-{[6,7-双(甲基氧基)喹啉-4-基]氧基}苯基)-n′-(4-氟苯基)环丙烷-1,1-二甲酰胺的代谢物 |
EP2981263B1 (en) | 2013-04-04 | 2022-06-29 | Exelixis, Inc. | Cabozantinib dosage form and use in the treatment of cancer |
UA123534C2 (uk) | 2014-02-14 | 2021-04-21 | Екселіксис, Інк. | Кристалічні тверді форми n-{4-[(6,7-диметоксихінолін-4-іл)окси]феніл}-n'-(4-флуорофеніл)циклопропан-1,1-дикарбоксаміду, способи отримання і способи застосування |
MA39735A (fr) | 2014-03-17 | 2017-01-25 | Exelixis Inc | Dosage de préparations de cabozantinib |
US11124481B2 (en) | 2014-07-31 | 2021-09-21 | Exelixis, Inc. | Method of preparing fluorine-18 labeled Cabozantinib and its analogs |
CA2957466C (en) | 2014-08-05 | 2023-10-17 | Exelixis, Inc. | Drug combinations to treat multiple myeloma |
CN105218445B (zh) * | 2015-08-25 | 2018-05-22 | 江苏中邦制药有限公司 | 一种酪氨酸激酶抑制剂Foretinib的制备方法 |
EP3442531A1 (en) | 2016-04-15 | 2019-02-20 | Exelixis, Inc. | Method of treating renal cell carcinoma using n-(4-(6,7-dimethoxyquinolin-4-yloxy) phenyl)-n'-(4-fluoropheny)cyclopropane-1,1-dicarboxamide, (2s)-hydroxybutanedioate |
CN110117254B (zh) * | 2019-06-20 | 2022-05-13 | 江苏君若药业有限公司 | 卡博替尼的制备方法 |
CN112194622A (zh) * | 2020-09-24 | 2021-01-08 | 上海毕得医药科技有限公司 | 一种5-氯喹啉-4-醇的合成方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2925655T3 (es) * | 2003-09-26 | 2022-10-19 | Exelixis Inc | Moduladores c-Met y métodos de uso |
EP1711495A2 (en) * | 2004-01-23 | 2006-10-18 | Amgen Inc. | Quinoline, quinazoline, pyridine and pyrimidine counds and their use in the treatment of inflammation, angiogenesis and cancer |
-
2009
- 2009-09-24 AR ARP090103685A patent/AR075084A1/es not_active Application Discontinuation
- 2009-09-24 UY UY0001032142A patent/UY32142A/es not_active Application Discontinuation
- 2009-09-24 TW TW098132200A patent/TW201035017A/zh unknown
- 2009-09-25 JP JP2011529236A patent/JP5587324B2/ja active Active
- 2009-09-25 WO PCT/US2009/058276 patent/WO2010036831A1/en active Application Filing
- 2009-09-25 US US12/566,707 patent/US8314232B2/en active Active
- 2009-09-25 EP EP09816875A patent/EP2339918A4/en not_active Withdrawn
- 2009-09-25 CN CN2009801472153A patent/CN102227164A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
JP5587324B2 (ja) | 2014-09-10 |
CN102227164A (zh) | 2011-10-26 |
EP2339918A1 (en) | 2011-07-06 |
AR075084A1 (es) | 2011-03-09 |
WO2010036831A1 (en) | 2010-04-01 |
JP2012503671A (ja) | 2012-02-09 |
US8314232B2 (en) | 2012-11-20 |
US20100081805A1 (en) | 2010-04-01 |
EP2339918A4 (en) | 2012-06-06 |
TW201035017A (en) | 2010-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY32142A (es) | Preparación de una quinoliniloxidifenilciclopropanodicarboxamida | |
IN2012DN02751A (es) | ||
CU20110052A7 (es) | Compuestos orgánicos | |
HN2011000341A (es) | Compuestos derivados de sulfonamidas, composiciones farmaceuticos y proceso de preparacion de los mismos | |
UY31367A1 (es) | Derivados de nicotinamida, su preparacion y su aplicacion en terapeutica | |
CY1123658T1 (el) | Μεθοδος για τη δημιουργια χημικων ενωσεων κινολονης | |
ECSP10010434A (es) | Inhibidores de hsp90 | |
CO6771439A2 (es) | Inhibidores de benzodioxano de la producción de leucotrieno | |
CR20110286A (es) | Proceso para la preparacion de derivados de l-alanina protegidos | |
CR20140071A (es) | Nuevos compuestos de 4-piperidinilo para uso como inhibidores de la tankirasa | |
EP2590649A4 (en) | PROCESS FOR SYNTHESIS OF SUBSTITUTED MORPHINANES | |
UY32517A (es) | Derivados de nicotinamida, su preparación y su aplicación en terapéutica | |
EA200900090A1 (ru) | Бензиламины, способ их получения и их применение в качестве противовоспалительных средств | |
BR122018074319B8 (pt) | Método para preparar um composto de fórmula 14 | |
MX2012001411A (es) | Proceso para la preparacion de derivados de acido 1-(2-halobifenil-4-il)-ciclopropanocarboxilico. | |
CR20120592A (es) | Intermedios de agomelatina y métodos de preparación de estos | |
MX2010009926A (es) | Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico. | |
MY164880A (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids | |
IN2014MN00971A (es) | ||
CY1119697T1 (el) | Μεθοδος παρασκευης ενωσεων α-γαλακτοζυλο κεραμιδιων | |
CR20110208A (es) | Proceso para la preparación de benzonorbornenos | |
ME00929B (me) | NOVI POSTUPAK ZA DOBlJANJE KRISTALNOG OBLIKA V AGOMELATIN A | |
UY35766A (es) | Proceso industrial para la síntesis de ingredientes activos esteroides | |
MX2013004193A (es) | Procedimiento para la preparacion de derivados de acido 3-(6-amino-piridin-3-il)-2-acrilico. | |
BR112012008952A2 (pt) | microbicidas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
104 | Application deemed to be withdrawn (no substantive examination fee paid) |
Effective date: 20101124 |